NCT01937767View on ClinicalTrials.gov

Remimazolam Phase II Cardiac Anesthesia Study

PHASE2CompletedINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 19, 2014

Conditions

General Anesthesia

Interventions

DRUG

Remimazolam

DRUG

Propofol

DRUG

Sevoflurane

DRUG

Remifentanil

DRUG

Fentanyl

DRUG

Rocuronium

Trial Locations (1)

04289

Herzzentrum Leipzig GmbH, Leipzig

Sponsors

Collaborators (1)

Aptiv Solutions

All Listed Sponsors

collaborator

Aptiv Solutions

INDUSTRY

lead

Paion UK Ltd.

INDUSTRY

NCT01937767 - Remimazolam Phase II Cardiac Anesthesia Study | Biotech Hunter | Biotech Hunter